Reply to 'Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance'

被引：5
作者：
Lee, Hee Jin [1 ]
Park, So Yeon [1 ,2 ]
机构：
[1] Seoul Natl Univ, Dept Pathol, Bundang Hosp, Songnam, Gyeonggi, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea
来源：
MODERN PATHOLOGY | 2013年 / 26卷 / 04期
关键词：
D O I：
10.1038/modpathol.2013.38
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：610 / 611
页数：2
相关论文
共 7 条
[1]   Frequency of HER2 Heterogeneity by Fluorescence In Situ Hybridization According to CAP Expert Panel Recommendations Time for a New Look at How to Report Heterogeneity [J].
Allison, Kimberly H. ;
Dintzis, Suzanne M. ;
Schmidt, Rodney A. .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2011, 136 (06) :864-871
[2]   Heterogeneous HER2 Gene Amplification Impact on Patient Outcome and a Clinically Relevant Definition [J].
Bartlett, Alastair I. ;
Starcyznski, Jane ;
Robson, Tammy ;
MacLellan, Alex ;
Campbell, Fiona M. ;
van de Vekle, Cornelis J. H. ;
Hasenburg, Annette ;
Markopoulos, Christos ;
Seynaeve, Caroline ;
Rea, Daniel ;
Bartlett, John M. S. .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2011, 136 (02) :266-274
[3]   Estrogen Receptor and Progesterone Receptor As Predictive Biomarkers of Response to Endocrine Therapy: A Prospectively Powered Pathology Study in the Tamoxifen and Exemestane Adjuvant Multinational Trial [J].
Bartlett, John M. S. ;
Brookes, Cassandra L. ;
Robson, Tammy ;
van de Velde, Cornelis J. H. ;
Billingham, Lucinda J. ;
Campbell, Fiona M. ;
Grant, Margaret ;
Hasenburg, Annette ;
Hille, Elysee T. M. ;
Kay, Charlene ;
Kieback, Dirk G. ;
Putter, Hein ;
Markopoulos, Christos ;
Kranenbarg, Elma Meershoek-Klein ;
Mallon, Elizabeth A. ;
Dirix, Luc ;
Seynaeve, Caroline ;
Rea, Daniel .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (12) :1531-1538
[4]   Disease-Free Survival According to Degree of HER2 Amplification for Patients Treated With Adjuvant Chemotherapy With or Without 1 Year of Trastuzumab: The HERA Trial [J].
Dowsett, Mitch ;
Procter, Marion ;
McCaskill-Stevens, Worta ;
de Azambuja, Evandro ;
Dafni, Urania ;
Rueschoff, Josef ;
Jordan, Bruce ;
Dolci, Stella ;
Abramovitz, Mark ;
Stoss, Oliver ;
Viale, Giuseppe ;
Gelber, Richard D. ;
Piccart-Gebhart, Martine ;
Leyland-Jones, Brian .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (18) :2962-2969
[5]   HER2/neu Gene Amplification Heterogeneity: The Significance of Cells With a 3:1 HER2/CEP17 Ratio [J].
Layfield, Lester J. ;
Schmidt, Robert L. .
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2012, 20 (06) :543-549
[6]   Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance [J].
Seol, Hyesil ;
Lee, Hyun Ju ;
Choi, Yoomi ;
Lee, Hee Eun ;
Kim, Yu Jung ;
Kim, Jee Hyun ;
Kang, Eunyoung ;
Kim, Sung-Won ;
Park, So Yeon .
MODERN PATHOLOGY, 2012, 25 (07) :938-948
[7]  
Vance GH, 2009, ARCH PATHOL LAB MED, V133, P611, DOI 10.1043/1543-2165-133.4.611
1